Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-15-000050
Filing Date
2015-01-06
Accepted
2015-01-05 20:48:48
Documents
14
Period of Report
2014-10-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT form10k.htm 10-K 1258248
2 EXHIBIT 10.101 ex10-101.htm EX-10.101 239080
3 EXHIBIT 10.102 ex10-102.htm EX-10.102 397481
4 EXHIBIT 23.1 ex23-1.htm EX-23.1 4487
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 18414
6 EXHIBIT 31.2 ex31-2.htm EX-31.2 18520
7 EXHIBIT 32.1 ex32-1.htm EX-32.1 6190
8 EXHIBIT 32.2 ex32-2.htm EX-32.2 6582
  Complete submission text file 0001493152-15-000050.txt   9735134

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE adxs-20141031.xml EX-101.INS 1050469
10 XBRL SCHEMA FILE adxs-20141031.xsd EX-101.SCH 87916
11 XBRL CALCULATION FILE adxs-20141031_cal.xml EX-101.CAL 68470
12 XBRL DEFINITION FILE adxs-20141031_def.xml EX-101.DEF 279158
13 XBRL LABEL FILE adxs-20141031_lab.xml EX-101.LAB 577556
14 XBRL PRESENTATION FILE adxs-20141031_pre.xml EX-101.PRE 396213
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-36138 | Film No.: 15507922
SIC: 2834 Pharmaceutical Preparations